Xeris Biopharma Holdings Inc (XERS)

Capital Expenditure

-$209.00K

Quarterly · Period ending: · USD

XERS logo

XERS Capital Expenditure

Latest reported-$209.00K
XERS Quarterly CapEx (-$342.00K → -$209.00K)
High-resolution chart · PNG

XERS capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-209,000
-325,000
-333,000
-363,000
-279,000
-13,000
-220,000
-87,000
-397,000
-164,000
-132,000
-345,000
-1,548,000
-238,000
-132,000
-176,000
-216,000
0
-131,000
-307,000
-218,000
-429,000
-225,000
0
-146,000
-26,000
-244,000
-369,000
-294,000
-200,000
-250,000
-771,000
-156,000
-333,000
-236,000
-25,000
-97,000
-342,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.